What is Treximet?
Treximet is a prescription medication used to treat migraine headaches with or without aura in adults [1]. It combines sumatriptan and naproxen sodium [1][2]. Sumatriptan is a triptan, and naproxen sodium is a nonsteroidal anti-inflammatory drug (NSAID) [1].
How does Treximet work?
Treximet works by narrowing blood vessels in the brain and blocking pain signals [1]. Sumatriptan targets specific serotonin receptors in the brain, which helps to constrict cranial blood vessels that may have dilated during a migraine. Naproxen sodium reduces inflammation and pain associated with migraines [2].
When will Treximet go generic?
The first generic versions of Treximet became available in late 2016 [3]. This followed the expiration of key patents and regulatory approvals for generic manufacturers [4].
What are the side effects of Treximet?
Common side effects of Treximet can include dizziness, drowsiness, tingling or numbness, flushing, and nausea [1]. More serious side effects, though rare, can include heart problems, stroke, or severe allergic reactions [1].
What are the alternatives to Treximet?
Alternatives to Treximet for migraine treatment include other triptans, NSAIDs, gepants, and ditans, depending on the individual's symptoms and medical history [5]. These may be used alone or in combination [5].
Where can I find more information about Treximet patents?
Information regarding Treximet patents and their expiration can be found on DrugPatentWatch.com [3][4].
Sources
1. https://www.webmd.com/drugs/2/205426/treximet-oral
2. https://www.rxlist.com/treximet-drug.htm
3. https://www.drugpatentwatch.com/treximet
4. https://www.drugpatentwatch.com/drug/205426/treximet-sumatriptan-naproxen
5. https://migraineagain.com/migraine-medications/